Effects of Rifampin and Multidrug Resistance Gene Polymorphism on Concentrations of Moxifloxacin
Marc Weiner(The University of Texas at San Antonio Health Science Center), Andrew Vernon(Centers for Disease Control and Prevention), Charles A. Peloquin(University of Florida), Chi-Cheng Luo(Centers for Disease Control and Prevention), Stefan Goldberg, Vipin Agarwal, Melissa Engle(The University of Texas at San Antonio Health Science Center), William J. Burman(Case Western Reserve University)
Cited by 106
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548